PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. With the PolyActiva technology, exceptional zero-order release profiles are achieved over treatment periods ranging from 6 to 12 months. Our mission is to become a leader in ophthalmic medicine by providing unique biodegradable implants with sustained drug delivery to improve patient outcomes and quality of life.
Looking for a particular PolyActiva employee's phone or email?
The PolyActiva annual revenue was $4 million in 2026.
Vanessa Waddell is the Chief Strategy Officer of PolyActiva.
24 people are employed at PolyActiva.
PolyActiva is based in Melbourne, Victoria.
The NAICS codes for PolyActiva are [3254, 32, 325, 32541].
The SIC codes for PolyActiva are [283, 28].